Pelthos Therapeutics Inc.
Ownership
Ownership Structure
Who owns Pelthos Therapeutics Inc. (PTHS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 36.4% of the shares are freely tradable; institutional investors hold 45.4%.
Largest Shareholders
No ownership data is available for this stock yet.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Friedberg Ezra M | Director | 80,484 | 595,582 $ | Oct 2, 2026 | direct |
| Greenleaf Peter | Director | 23,087 | 170,844 $ | Oct 2, 2026 | direct |
| Pauls Matthew | Director | 13,578 | 100,477 $ | Oct 2, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | Greenleaf Peter | Director | Sell | 797 | 21.17 | 16,872 |
| Oct 2, 2026 | Friedberg Ezra M | Director | Sell | 558 | 20.72 | 11,560 |
| Oct 2, 2026 | Pauls Matthew | Director | Sell | 786 | 21.00 | 16,506 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.